Showing results (2661-2670 of 2,892) with videos related to
Sort By:
Pageof 290
The Oncologist|February 12, 2020
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable ResponseAndge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, et al.The Oncologist|April 18, 2015
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapiesSiraj M Ali, Eric M Sanford, Samuel J Klempner, et al.Journal of the National Cancer Institute|June 10, 2020
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder CancerMarco Bandini, Jeffrey S Ross, Daniele Raggi, et al.Circulation|July 6, 2006
Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failureStephen D Surgenor, Gordon R DeFoe, Mary P Fillinger, et al.The Oncologist|December 17, 2015
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic AlterationsSiraj M Ali, Sumanta K Pal, Kai Wang, et al.Cell Reports|February 14, 2013
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factorHisham Mohammed, Clive D'Santos, Aurelien A Serandour, et al.Clinical Chemistry|October 9, 2021
Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer PatientsRichard S P Huang, Jinpeng Xiao, Dean C Pavlick, et al.Human Pathology|October 3, 2000
Pathology residents' use of a Web-based tutorial to improve Gleason grading of prostate carcinoma on needle biopsiesJ D Kronz, M A Silberman, W C Allsbrook, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2018
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II StudyAndrea Necchi, Andrea Anichini, Daniele Raggi, et al.The Oncologist|February 25, 2014
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencingJeffrey S Ross, Kai Wang, Laurie Gay, et al.Pageof 290